Security Snapshot

Sonic Healthcare Ltd - Common Stock - Foreign Institutional Ownership

CUSIP: 006821120

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

1

Shares (Excl. Options)

273,100

Price

$15.09

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock - Foreign
Price per share
$15.09
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
273,100
Total reported value
$4,120,758
% of total 13F portfolios
0%
Share change
+38,148
Value change
+$575,608
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • 006821120 - Sonic Healthcare Ltd - Common Stock - Foreign is tracked under CUSIP 006821120.
  • 1 institution reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 1 to 1 between Q3 2025 and Q4 2025.
  • Reported value moved from $3,333,226 to $4,120,758.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 1 institution filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 006821120?
CUSIP 006821120 identifies 006821120 - Sonic Healthcare Ltd - Common Stock - Foreign in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 1 institutional investors reported holding 273,100 shares of Sonic Healthcare Ltd - Common Stock - Foreign.

Institutional Holders of Sonic Healthcare Ltd - Common Stock - Foreign across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 273,100 $4,120,758 +$575,608 $15.09 1
2025 Q3 234,952 $3,333,226 +$10,030 $14.19 1
2025 Q2 234,245 $4,130,171 +$342,393 $17.63 1
2025 Q1 214,826 $3,457,877 +$99,989 $16.10 1
2024 Q4 208,614 $3,487,574 -$94,004 $16.72 1
2024 Q3 214,237 $4,033,097 +$106,796 $18.83 1
2024 Q2 208,564 $3,659,188 +$1,432,681 $17.54 1
2024 Q1 126,905 $2,432,132 +$55,425 $19.16 1
2023 Q4 124,013 $2,711,036 +$2,674,878 $21.86 1
2023 Q3 1,880 $36,158 -$6,858,243 $19.23 1
2023 Q2 291,118 $6,894,401 +$445,822 $23.69 2
2023 Q1 272,303 $6,350,131 +$5,206,653 $23.31 2
2022 Q4 49,100 $1,001,891 -$3,350,109 $20.41 1
2022 Q3 221,337 $4,352,000 $19.66 1
2022 Q2 221,337 $5,024,000 -$1,513,031 $22.70 1
2022 Q1 287,995 $7,673,000 -$468,594 $26.64 1
2021 Q4 305,583 $10,360,000 $33.90 1
2021 Q3 305,583 $8,975,000 -$409,566 $29.37 1
2021 Q2 319,528 $9,212,000 +$50,712 $28.83 1
2021 Q1 317,769 $8,493,000 -$1,630,318 $26.73 1
2020 Q4 378,768 $9,397,000 $24.81 1
2020 Q3 378,768 $9,002,000 -$2,619,927 $23.77 1
2020 Q2 489,004 $10,245,000 +$172,320 $20.95 1
2020 Q1 480,779 $7,159,000 +$106,318 $14.89 1
2019 Q4 473,639 $9,572,000 -$3,089,909 $20.21 1
2019 Q3 626,533 $12,138,000 +$216,438 $19.37 1
2019 Q2 615,361 $11,703,000 +$11,703,000 $19.02 1
2019 Q1 0 $0 -$9,588,000 $15.09 0
2018 Q4 615,998 $9,588,000 +$674,493 $15.56 1
2018 Q3 572,664 $10,321,000 +$601,943 $18.02 1
2018 Q2 539,265 $9,774,000 +$132,147 $18.12 1
2018 Q1 531,974 $9,336,000 $17.55 1
2017 Q4 531,974 $9,512,000 $17.88 1
2017 Q3 531,974 $8,728,000 +$8,728,000 $16.41 1
2016 Q4 0 $0 -$3,652,000 $15.09 0
2016 Q3 216,810 $3,652,000 -$177,201 $16.84 1
2016 Q2 227,330 $3,648,000 -$1,972,356 $16.05 1
2016 Q1 350,240 $5,060,000 +$657,638 $14.45 1
2015 Q4 304,720 $3,962,000 +$340,009 $13.00 1
2015 Q3 279,631 $3,584,000 +$44,667 $12.82 2
2015 Q2 201,635 $3,312,000 +$45,089 $16.43 1
2015 Q1 198,890 $3,106,000 +$166,864 $15.62 1
2014 Q4 188,205 $2,849,000 -$162,806 $15.14 1
2014 Q3 198,960 $3,054,000 +$21,797 $15.35 1
2014 Q2 197,540 $3,231,000 -$13,576 $16.36 1
2014 Q1 198,370 $3,175,000 +$12,004 $16.01 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .